Methylene blue in the treatment of refractory shock from an amlodipine overdose.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21546119.
- Also identified by DOI 10.1016/j.annemergmed.2011.02.025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Amlodipine is a potent vasodilator with a long half-life and delayed onset of action that is particularly concerning after an overdose. Vasodilation occurs through stimulation of nitric oxide release with increased cyclic guanosine monophosphate (cGMP) production. Methylene blue inhibits guanylate cyclase. This enzyme is responsible for the production of cGMP. Methylene blue also has the ability to scavenge nitric oxide, as well as inhibit nitric oxide synthase. We report the use of methylene blue for refractory shock in a patient with amlodipine toxicity.
Medical subject headings
- Amlodipine
- Cyclic GMP
- Methylene Blue
- Shock
- Vasodilator Agents